1. Home
  2. AVTX vs PMM Comparison

AVTX vs PMM Comparison

Compare AVTX & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVTX
  • PMM
  • Stock Information
  • Founded
  • AVTX 2011
  • PMM 1989
  • Country
  • AVTX United States
  • PMM United States
  • Employees
  • AVTX N/A
  • PMM N/A
  • Industry
  • AVTX Biotechnology: Pharmaceutical Preparations
  • PMM Investment Managers
  • Sector
  • AVTX Health Care
  • PMM Finance
  • Exchange
  • AVTX Nasdaq
  • PMM Nasdaq
  • Market Cap
  • AVTX 248.3M
  • PMM 262.2M
  • IPO Year
  • AVTX 2015
  • PMM N/A
  • Fundamental
  • Price
  • AVTX $18.62
  • PMM $6.10
  • Analyst Decision
  • AVTX Strong Buy
  • PMM
  • Analyst Count
  • AVTX 9
  • PMM 0
  • Target Price
  • AVTX $30.14
  • PMM N/A
  • AVG Volume (30 Days)
  • AVTX 351.6K
  • PMM 118.3K
  • Earning Date
  • AVTX 11-06-2025
  • PMM 01-01-0001
  • Dividend Yield
  • AVTX N/A
  • PMM 4.68%
  • EPS Growth
  • AVTX N/A
  • PMM N/A
  • EPS
  • AVTX N/A
  • PMM 0.23
  • Revenue
  • AVTX $192,000.00
  • PMM N/A
  • Revenue This Year
  • AVTX N/A
  • PMM N/A
  • Revenue Next Year
  • AVTX N/A
  • PMM N/A
  • P/E Ratio
  • AVTX N/A
  • PMM $26.52
  • Revenue Growth
  • AVTX N/A
  • PMM N/A
  • 52 Week Low
  • AVTX $3.39
  • PMM $5.00
  • 52 Week High
  • AVTX $19.41
  • PMM $6.42
  • Technical
  • Relative Strength Index (RSI)
  • AVTX 64.08
  • PMM 50.11
  • Support Level
  • AVTX $16.75
  • PMM $6.04
  • Resistance Level
  • AVTX $19.29
  • PMM $6.10
  • Average True Range (ATR)
  • AVTX 1.41
  • PMM 0.05
  • MACD
  • AVTX 0.17
  • PMM -0.00
  • Stochastic Oscillator
  • AVTX 87.31
  • PMM 48.45

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: